Who Owns ABVC BioPharma Stock?
NASDAQ: ABVCHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 4.08%
- Held by insiders
- 18.09%
- Institutional holders
- 15
- Institutions 4.1%
- Insiders 18.1%
- Public and other 77.8%
Who owns ABVC BioPharma stock?
Institutional investors own about 4.1% of ABVC BioPharma's shares, spread across 15 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 18.09% of ABVC.
The largest institutional holders are Vanguard Capital Management LLC (1.40%), Geode Capital Management, LLC (0.85%) and Vanguard Fiduciary Trust Co (0.36%). Together, the top 10 institutions control 4.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ABVC positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ABVC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 374.50K | 1.40% | +96.5% |
| Geode Capital Management, LLC | 228.04K | 0.85% | +3.1% |
| Vanguard Fiduciary Trust Co | 97.36K | 0.36% | 0.0% |
| State Street Corporation | 72.80K | 0.27% | 0.0% |
| Citadel Advisors Llc | 72.09K | 0.27% | +100.0% |
| Blackrock Inc. | 56.44K | 0.21% | 0.0% |
| Northern Trust Corporation | 48.64K | 0.18% | +51.6% |
| Xtx Topco Ltd | 48.28K | 0.18% | +100.0% |
| PanAgora Asset Management, Inc. | 36.68K | 0.14% | +100.0% |
| UBS Group AG | 34.12K | 0.13% | +1826.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ABVC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 208.28K | 0.78% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 115.24K | 0.43% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 109.47K | 0.41% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 35.53K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 31.05K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 14.82K | 0.06% |
Frequently asked questions
Who is the largest shareholder of ABVC BioPharma?
Vanguard Capital Management LLC is the largest institutional shareholder of ABVC, owning 1.40% of shares outstanding (374.50K shares) as of its latest 13F filing.
What percentage of ABVC BioPharma is owned by institutions?
Institutions own about 4.1% of ABVC shares and 5.0% of the public float.
How much of ABVC BioPharma do insiders own?
Insiders, such as officers and directors, own about 18.09% of ABVC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.